Related Experiment Video
Updated: Mar 17, 2026

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction
Modar Kassan1, Karima Ait-Aissa1, Eman Radwan1
1From the Department of Physiology, Hypertension and Renal Center of Excellence, Tulane University, New Orleans, LA (M.K., K.M.); Department of Physiological Sciences, EVMS, Norfolk, VA (M.K., K.A.-A., E.R., V.M., S.H., S.B., K.M.); Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA (W.Z., M.T); and Department of Internal Medicine, University of Iowa, Iowa City (K.M., M.G., K.I.).
Insights
Stromal interaction molecule 1 (STIM1) in smooth muscle drives hypertension and cardiovascular damage by increasing endoplasmic reticulum stress. Blocking STIM1 or CHOP protects against these conditions, highlighting STIM1 as a therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Hypertension Research
Background:
- Chronic hypertension is a major risk factor for cardiovascular diseases, heart failure, and stroke.
- Stromal interaction molecule 1 (STIM1) expression is implicated in cardiovascular pathologies.
Purpose of the Study:
- To investigate the role of smooth muscle STIM1 in angiotensin II-induced hypertension and associated cardiovascular pathologies.
- To elucidate the mechanisms linking STIM1, endoplasmic reticulum stress, and vascular dysfunction.
Main Methods:
- Utilized angiotensin II infusion in wild-type mice and mice with smooth muscle-specific STIM1 deficiency (Stim1(SMC-/-)).
- Assessed cardiac hypertrophy, fibrosis, endothelial dysfunction, and vascular nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
- Examined the role of CCAAT-enhancer-binding protein homologous protein (CHOP) by using CHOP knockout mice (CHOP(-/-)).
Main Results:
- Angiotensin II infusion induced hypertension, cardiac hypertrophy, fibrosis, and endothelial dysfunction, with increased STIM1 expression.
- Mice lacking smooth muscle STIM1 (Stim1(SMC-/-)) or CHOP (CHOP(-/-)) were resistant to these pathologies.
- Smooth muscle STIM1 mediated endoplasmic reticulum stress-induced vascular dysfunction via TGF-β and NADPH oxidase pathways.
- Hypertensive wild-type mice exhibited increased vascular NADPH oxidase activity and reduced eNOS/cGMP/nitrite signaling, which was prevented in Stim1(SMC-/-) and CHOP(-/-) mice.
Conclusions:
- Smooth muscle STIM1 is crucial for developing hypertension and associated cardiovascular pathologies.
- STIM1-dependent endoplasmic reticulum stress contributes to vascular dysfunction in hypertension.
- Targeting smooth muscle STIM1 offers a potential therapeutic strategy for cardiovascular diseases.
Objectives:
Chronic hypertension is the most critical risk factor for cardiovascular disease, heart failure, and stroke.
Approach And Results:
Here we show that wild-type mice infused with angiotensin II develop hypertension, cardiac hypertrophy, perivascular fibrosis, and endothelial dysfunction with enhanced stromal interaction molecule 1 (STIM1) expression in heart and vessels. All these pathologies were significantly blunted in mice lacking STIM1 specifically in smooth muscle (Stim1(SMC-/-)). Mechanistically, STIM1 upregulation during angiotensin II-induced hypertension was associated with enhanced endoplasmic reticulum stress, and smooth muscle STIM1 was required for endoplasmic reticulum stress-induced vascular dysfunction through transforming growth factor-β and nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways. Accordingly, knockout mice for the endoplasmic reticulum stress proapoptotic transcriptional factor, CCAAT-enhancer-binding protein homologous protein (CHOP(-/-)), were resistant to hypertension-induced cardiovascular pathologies. Wild-type mice infused with angiotensin II, but not Stim1(SMC-/-) or CHOP(-/-) mice showed elevated vascular nicotinamide adenine dinucleotide phosphate oxidase activity and reduced phosphorylated endothelial nitric oxide synthase, cGMP, and nitrite levels.
Conclusions:
Thus, smooth muscle STIM1 plays a crucial role in the development of hypertension and associated cardiovascular pathologies and represents a promising target for cardiovascular therapy.
More Related Videos
09:05Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
08:59Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle
Published on: May 5, 2022
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Hypertension II: Pathophysiology
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Functions of Smooth Muscles
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Antihypertensive Drugs: Action of Calcium Channel Blockers